Variant report
Variant | esv3413838 |
---|---|
Chromosome Location | chr11:59483281-59483865 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr11:59483560-59483811 | K562 | blood: | n/a | n/a |
2 | CEBPD | chr11:59483600-59483863 | K562 | blood: | n/a | n/a |
3 | CUX1 | chr11:59483609-59483840 | K562 | blood: | n/a | n/a |
4 | EP300 | chr11:59483618-59483797 | K562 | blood: | n/a | n/a |
5 | SPI1 | chr11:59483210-59483339 | K562 | blood: | n/a | chr11:59483288-59483301 chr11:59483287-59483300 |
6 | TAL1 | chr11:59483536-59483862 | K562 | blood: | n/a | n/a |
7 | TEAD4 | chr11:59483525-59483887 | K562 | blood: | n/a | n/a |
8 | TEAD4 | chr11:59483473-59483945 | K562 | blood: | n/a | n/a |
9 | ZMIZ1 | chr11:59483595-59483844 | K562 | blood: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:59483722..59486597-chr11:59487703..59490469,2 | K562 | blood: | |
2 | chr11:59436021..59437623-chr11:59481506..59483515,2 | K562 | blood: | |
3 | chr11:59479738..59481796-chr11:59482319..59484828,2 | K562 | blood: | |
4 | chr11:59479738..59482245-chr11:59482319..59485600,3 | K562 | blood: | |
5 | chr11:59436021..59438206-chr11:59481506..59484047,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR10V1 | TF binding region |
ENSG00000255355 | chromatin interactions |
ENSG00000172289 | chromatin interactions |
ENSG00000166900 | chromatin interactions |
ENSG00000166889 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537759717 | chr11:59483330-59483331 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
2 | rs555932242 | chr11:59483342-59483343 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs473979 | chr11:59483353-59483354 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs545066923 | chr11:59483412-59483413 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
5 | rs370990790 | chr11:59483413-59483414 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
6 | rs182692898 | chr11:59483418-59483419 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
7 | rs115306679 | chr11:59483456-59483457 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
8 | rs78022026 | chr11:59483471-59483472 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs112486949 | chr11:59483478-59483479 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
10 | rs145503579 | chr11:59483501-59483502 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
11 | rs188211699 | chr11:59483502-59483503 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
12 | rs533392563 | chr11:59483513-59483514 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
13 | rs147725610 | chr11:59483522-59483523 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
14 | rs192786022 | chr11:59483611-59483612 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
15 | rs534306139 | chr11:59483635-59483636 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
16 | rs375811296 | chr11:59483636-59483637 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
17 | rs518427 | chr11:59483693-59483694 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs567364009 | chr11:59483697-59483698 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
19 | rs537747149 | chr11:59483755-59483756 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
20 | rs556068477 | chr11:59483756-59483757 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
21 | rs577753406 | chr11:59483765-59483766 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
22 | rs538421697 | chr11:59483790-59483791 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
23 | rs141196242 | chr11:59483805-59483806 | Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
24 | rs114787968 | chr11:59483815-59483816 | Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
25 | rs542784128 | chr11:59483836-59483837 | Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
26 | rs540684 | chr11:59483848-59483849 | Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495309 | CNVD |
Autism | 20808228 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:59478200-59489600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr11:59483200-59483600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr11:59483200-59483600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
4 | chr11:59483200-59483800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr11:59483200-59483800 | Enhancers | K562 | blood |
6 | chr11:59483400-59483800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |